Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 13, 1992
Evaluation of tumor cell heterogeneity based on response to chemotherapyB L AsselinAdvances in Experimental Medicine and Biology|September 29, 1999
The three asparaginases. Comparative pharmacology and optimal use in childhood leukemiaB L AsselinClinics in Perinatology|March 1, 1987
Maternal disease as a consideration in lactation managementB L Asselin, R A LawrenceThe Journal of Pediatrics|June 1, 1996
Right atrial thrombi in children with cancer and indwelling cathetersD N Korones, C J Buzzard, B L Asselin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Comparative pharmacokinetic studies of three asparaginase preparationsB L Asselin, J C Whitin, D J Coppola, et al.Cancer Research|August 1, 1989
In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginaseB L Asselin, D Ryan, C N Frantz, et al.Cancer Research|December 15, 1991
Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitorB L Asselin, M Y Lorenson, J C Whitin, et al.Journal of Pediatric Hematology/Oncology|February 25, 1999
Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemiaB L Asselin, S Kreissman, D J Coppola, et al.Blood|February 27, 2001
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01L B Silverman, R D Gelber, V K Dalton, et al.Leukemia|February 24, 2001
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)L B Silverman, L Declerck, R D Gelber, et al.Pageof 2